{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T18:46:43Z","timestamp":1774896403000,"version":"3.50.1"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Crohn's and Colitis"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1016\/j.crohns.2010.02.007","type":"journal-article","created":{"date-parts":[[2010,3,22]],"date-time":"2010-03-22T04:21:09Z","timestamp":1269231669000},"page":"466-470","source":"Crossref","is-referenced-by-count":20,"title":["A role for B12 in inflammatory bowel disease patients with suppurative dermatoses? An experience with high dose vitamin B12 therapy"],"prefix":"10.1093","volume":"4","author":[{"given":"Marianne","family":"Mortimore","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy H.J.","family":"Florin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"key":"10.1016\/j.crohns.2010.02.007_bib1","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1016\/j.gastro.2003.08.025","article-title":"American Gastroenterological Association Clinical Practice Committee. AGA technical review on perianal Crohn's disease","volume":"125","author":"Sandborn","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.crohns.2010.02.007_bib2","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1136\/gut.2005.082909","article-title":"The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications","volume":"55","author":"Satsangi","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.crohns.2010.02.007_bib3","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jaad.2008.11.911","article-title":"Hidradenitis suppurativa: a comprehensive review","volume":"60","author":"Alikhan","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.crohns.2010.02.007_bib4","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1016\/S0016-5085(03)00327-5","article-title":"Skin signs of gastrointestinal disease","volume":"124","author":"Braverman","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.crohns.2010.02.007_bib5","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0190-9622(97)80320-9","article-title":"Cutaneous Crohn's disease in children","volume":"36","author":"Polysangam","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.crohns.2010.02.007_bib6","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1600-0560.1998.tb01722.x","article-title":"Sterile neutrophilic folliculitis with perifollicular vasculopathy: a distinctive cutaneous reaction pattern reflecting systemic disease","volume":"25","author":"Magro","year":"1998","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.crohns.2010.02.007_bib7","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0025-6196(12)61046-5","article-title":"The biochemical basis of cobalamin deficiency","volume":"69","author":"Tefferi","year":"1994","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.crohns.2010.02.007_bib8","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.expneurol.2004.12.020","article-title":"Cobalamin (vitamin B12) in subacute combined degeneration and beyond: traditional interpretations and novel theories","volume":"192","author":"Scalabrino","year":"2005","journal-title":"Exp Neurol"},{"key":"10.1016\/j.crohns.2010.02.007_bib9","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1177\/15648265080292S108","article-title":"Indicators for assessing folate and vitamin B12 status and for monitoring the efficacy of intervention strategies","volume":"29","author":"Green","year":"2008","journal-title":"Food Nutr Bull"},{"key":"10.1016\/j.crohns.2010.02.007_bib10","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1177\/15648265080292S110","article-title":"The use of blood concentrations of vitamins and their respective functional indicators to define folate and vitamin B12 status","volume":"29","author":"Selhub","year":"2008","journal-title":"Food Nutr Bull"},{"key":"10.1016\/j.crohns.2010.02.007_bib11","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3122\/jabfm.2009.01.080113","article-title":"Effectiveness of vitamin B12 in treating recurrent aphthous stomatitis: a randomized, double-blind, placebo-controlled trial","volume":"22","author":"Volkov","year":"2009","journal-title":"J Am Board Fam Med."},{"key":"10.1016\/j.crohns.2010.02.007_bib12","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1272\/jnms.73.65","article-title":"Vitamin B12 could be a \u201cmaster key\u201d in the regulation of multiple pathological processes","volume":"73","author":"Volkov","year":"2006","journal-title":"J Nippon Med Sch"},{"key":"10.1016\/j.crohns.2010.02.007_bib13","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1111\/j.1365-2133.2004.05866.x","article-title":"Topical vitamin B12\u2014a new therapeutic approach in atopic dermatitis\u2014evaluation of efficacy and tolerability in a randomized placebo controlled multicentre clinical trial","volume":"150","author":"Stucker","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.crohns.2010.02.007_bib14","first-page":"834","article-title":"A new method in seborrhic skin diseases.","volume":"126","author":"Niemand-Anderssen","year":"1952","journal-title":"Dermatol Wochenschr"},{"issue":"33","key":"10.1016\/j.crohns.2010.02.007_bib15","first-page":"1293","article-title":"Experience with vitamin B12 in the treatment of dermatoses, particularly of seborroic origin","volume":"49","author":"Blut","year":"1954","journal-title":"Med Klin (Munich)"},{"key":"10.1016\/j.crohns.2010.02.007_bib16","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0021-8707(51)90059-7","article-title":"Vitamin B12 therapy in allergy and chronic dermatoses","volume":"22","author":"Simon","year":"1951","journal-title":"J Allergy"},{"key":"10.1016\/j.crohns.2010.02.007_bib17","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/00004836-199503000-00018","article-title":"Hidradenitis suppurativa in Crohn's disease. A further support to this association","volume":"20","author":"Tsianos","year":"1995","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.crohns.2010.02.007_bib18","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/BF00341181","article-title":"The differential diagnosis and comorbidity of hidradenitis suppurativa and perianal Crohn's disease","volume":"8","author":"Church","year":"1993","journal-title":"Int J Colorect Dis"},{"key":"10.1016\/j.crohns.2010.02.007_bib19","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1365-2559.1993.tb00468.x","article-title":"Granulomatous hidradenitis suppurativa and cutaneous Crohn's disease","volume":"23","author":"Attanoos","year":"1993","journal-title":"Histopathology"},{"key":"10.1016\/j.crohns.2010.02.007_bib20","first-page":"928","article-title":"Hidradenitis suppurativa and Crohn's disease in two families: a significant association?","volume":"87","author":"Gower-Rousseau","year":"1992","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.crohns.2010.02.007_bib21","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1365-2133.1992.tb11830.x","article-title":"Crohn's disease in association with hidradenitis suppurativa","volume":"126","author":"Burrows","year":"1992","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.crohns.2010.02.007_bib22","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/j.1365-2133.1991.tb14178.x","article-title":"Hidradenitis suppurativa in Crohn's disease","volume":"125","author":"Ostlere","year":"1991","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.crohns.2010.02.007_bib23","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1157\/13125587","article-title":"Open-label infliximab therapy in Crohn's disease: a long term multicentre study of efficacy, safety and predictors of response","volume":"31","author":"Gonzalez-Lama","year":"2008","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.crohns.2010.02.007_bib24","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1111\/j.1365-4632.2007.03293.x","article-title":"Is there a role for infliximab in the current therapy of hidradenitis suppurativa? A report of three treated cases","volume":"46","author":"Moschella","year":"2007","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.crohns.2010.02.007_bib25","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1080\/09546630410024547","article-title":"Treatment of hidradenitis suppurativa with infliximab in a patient with Crohn's disease","volume":"16","author":"Rosi","year":"2005","journal-title":"J Dermatolog Treat"},{"issue":"5 Suppl","key":"10.1016\/j.crohns.2010.02.007_bib26","doi-asserted-by":"crossref","first-page":"S275","DOI":"10.1016\/S0190-9622(03)01132-0","article-title":"Infliximab for the treatment of hidradenitis suppurativa","volume":"49","author":"Lebwohl","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.crohns.2010.02.007_bib27","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1111\/j.1572-0241.2002.05950.x","article-title":"Axillary hidradenitis suppurativa successfully treated with infliximab in a Crohn's disease patient","volume":"97","author":"Katsanos","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.crohns.2010.02.007_bib28","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/00054725-200111000-00008","article-title":"Hidradenitis suppurativa and Crohn's disease: response to treatment with infliximab","volume":"7","author":"Martinez","year":"2001","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.crohns.2010.02.007_bib29","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1042\/0264-6021:3420021","article-title":"S-Adenosylmethionine attenuates the lipopolysaccharide-induced expression of the gene for tumour necrosis factor \u03b1","volume":"342","author":"Watson","year":"1999","journal-title":"Biochem J"},{"key":"10.1016\/j.crohns.2010.02.007_bib30","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.molmed.2006.04.008","article-title":"New insights into the pathophysiology of cobalamin deficiency","volume":"12","author":"Scalabrino","year":"2006","journal-title":"TRENDS in Mol Med"},{"key":"10.1016\/j.crohns.2010.02.007_bib31","doi-asserted-by":"crossref","first-page":"285","DOI":"10.2165\/00128071-200809050-00002","article-title":"EGFR inhibitor-associated acneiform folliculitis: assessment and management","volume":"9","author":"Duvic","year":"2008","journal-title":"Am J Clin Dermatol"}],"container-title":["Journal of Crohn's and Colitis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1873994610000425?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1873994610000425?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/ecco-jcc\/article-pdf\/4\/4\/466\/7799939\/4-4-466.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,22]],"date-time":"2017-08-22T19:34:04Z","timestamp":1503430444000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/article-lookup\/doi\/10.1016\/j.crohns.2010.02.007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["S1873994610000425"],"URL":"https:\/\/doi.org\/10.1016\/j.crohns.2010.02.007","relation":{},"ISSN":["1873-9946"],"issn-type":[{"value":"1873-9946","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10]]}}}